SuzanneBMerrillMD

PubMed

• Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology Residents.
  Marchetti, K., Ferreri, C., Bethel, E., Lesser-Lee, B., Daignault-Newton, S., Merrill, S., Badalato, G., Brown, E., Guzzo, T., Houston Thompson, R., Klausner, A., Lee,...> ;Urology. 2024 Feb 7
• Significant Bleeding Complications Following Transrectal Prostate Needle Biopsy: Incidence, Predictors, and Management.
  Jay Fuletra, Chris Rjepaj, Joseph Y Clark, John J Knoedler, Susan M MacDonald, Matthew G Kaag, Suzanne B Merrill, Jay D Raman> ;Urology Practice. 2023 Jan 1
• 1 citations
  Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
  Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman, Jenna M Craig, Lan L Gellert, Mauro A A Castro, A Gordon Robertson, Fengshen Kuo, Irina Os...> ;Nature Communications. 2022 Dec 23
• 9 citations
  FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
  Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman, Jenna M Craig, Lan L Gellert, Mauro A A Castro, A Gordon Robertson, Fengshen Kuo, Irina Os...> ;Nature Communications. 2022 Nov 2
• Impact of an inpatient advanced practice provider on hospital length of stay after major urologic oncology procedures.
  Benjamin P Hull, Michael D Humphrey, Kathleen K Lehman, Matthew G Kaag, Suzanne B Merrill, Jay D Raman> ;Urologic Oncology. 2022 Sep 1
• Patient Perceptions Regarding Routine Oncologic Follow-Up for Urologic Malignancies.
  Sarah A Strausser, R Grant Owens, Tyler Vu, Ellius Kwok, Eric W Schaefer, Suzanne Boltz, Alireza Aminsharifi, Matthew Kaag, Jay D Raman, Suzanne B Merrill> ;Clinical Genitourinary Cancer. 2022 Jun 1
• Diagnostic Imaging in Low-Risk Prostate Cancer: More Harm Than Good?
  Justin Loloi, Joshua M Eccles, Grant Owens, Erik Lehman, Matthew G Kaag, Jay D Raman, Suzanne B Merrill> ;Urology Practice. 2022 Mar 1
• 4 citations
  Integration of Robotics in Urology Residency Programs: an Unchecked Technological Revolution.
  Christian M Hague, Suzanne B. Merrill> ;Current Urology Reports. 2021 Sep 17
• 8 citations
  Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship
  Shayann Ramedani, Joseph Y. Clark, John J. Knoedler, Susan MacDonald, Matthew Kaag, Suzanne B. Merrill, Jay D. Raman> ;Prostate International. 2021 May 27
• Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?
  R. Grant Owens, Justin Loloi, Erik Lehman, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill> ;Urologic Oncology. 2021 Feb 17
• Optimizing Outcomes in Urological Surgery: Postoperative Care.
  Angela Smith, Megan Anders, Gregory Auffenberg, Kristin Chrouser, Siamak Daneshmand, Chad Elllimootil, Jane Fellows, Scott Gilbert, John L Gore, Suzanne Merrill, Kenne...> ;Urology Practice. 2020 Nov 1
• Patterns of surveillance intensity in kidney cancer.
  Suzanne B. Merrill, Justin Loloi, Eric W. Schaefer, Christopher S. Hollenbeak> ;International Urology and Nephrology. 2021 Mar 1
• 2 citations
  Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass Biopsy
  Lauren M Nahouraii, Jordan L Allen, Suzanne B. Merrill, Erik Lehman, Matthew Kaag, Jay D. Raman> ;Journal of Kidney Cancer and VHL. 2020 Aug 25
• 1 citations
  Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma.
  Leo D. Dreyfuss, Viraj A. Master, Jay D. Raman, Philippe E. Spiess, Shane A. Wells, Suzanne B. Merrill, Charles C. Peyton, Dhyana Sankar, Brian S. Sohl, Dattatraya Pat...> ;Urology. 2020 Aug 8
• Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy
  Jay Fuletra, Andrew Watts, Matthew Kaag, Erik Lehman, Jay D. Raman, Suzanne B. Merrill> ;World Journal of Urology. 2021 Jun 1
• 1 citations
  Hemostatic agent use during partial nephrectomy: trends, outcomes, and associated costs
  Adri Durant, Erik Lehman, Haley Robyak, Suzanne B. Merrill, Matthew Kaag, Jay D. Raman> ;International Urology and Nephrology. 2020 Jun 15
• 7 citations
  The Balance between Open and Robotic Training among Graduating Urology Residents—Does Surgical Technique Need Monitoring?
  Suzanne B. Merrill, Brian S. Sohl, R. Houston Thompson, Adam C. Reese, Dipen J. Parekh, John H. Lynch, Baruch M. Grob, Daniel H. Williams, Richard K. Lee, Stanley Zasl...> ;The Journal of Urology. 2020 May 1
• 35 citations
  Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes.
  Huili Li, Qingzhao Zhang, Lauren Shuman, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill, David J. DeGraff, Joshua I. Warrick, Guoli Chen> ;Scientific Reports. 2020 Jan 29
• 6 citations
  Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival.
  Suzanne B. Merrill, Brian S. Sohl, Ashiya Hamirani, Erik Lehman, Kathleen Lehman, Matthew Kaag, Jay D. Raman> ;Clinical Genitourinary Cancer. 2019 Apr 1
• 10 citations
  Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
  Michael Zaleski, Augustyna Gogoj, Vonn Walter, Jay D. Raman, Matthew Kaag, Suzanne B. Merrill, Joseph J. Drabick, Monika Joshi, Sheldon L. Holder, David J. DeGraff, Jo...> ;Human Pathology. 2019 Feb 1
• 1 citations
  More Isn't Always Better: Time to Derive a Different Strategy for Renal Cell Carcinoma Surveillance
  Suzanne B. Merrill> ;European Urology. 2019 Feb 1
• 145 citations
  Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
  Joshua I. Warrick, Gottfrid Sjödahl, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill, Lauren Shuman, Guoli Chen, Vonn Walter, David J. DeGraff> ;European Urology. 2019 Jan 1
• 6 citations
  Oncologic surveillance following radical cystectomy: an individualized risk-based approach
  Suzanne B. Merrill, Stephen A. Boorjian, R. Houston Thompson, Sarah P. Psutka, John C. Cheville, Prabin Thapa, Matthew K. Tollefson, Igor Frank> ;World Journal of Urology. 2017 Jul 6
• 3 citations
  Postoperative Surveillance for Renal Cell Carcinoma
  Suzanne B. Merrill> ;The Urologic Clinics of North America. 2017 May 1
• 12 citations
  Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study.
  Daniel D. Joyce, Sarah P. Psutka, Ryan T. Groeschl, R. Houston Thompson, Stephen A. Boorjian, John C. Cheville, Suzanne B. Stewart-Merrill, Christine M. Lohse, Brian A...> ;Urology. 2017 Jan 1
• Join now to see all

Journal Articles

• Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
  Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
• Oncologic Surveillance Following Radical Cystectomy: An Individualized Risk-based Approach  
  Merrill SB, Boorjian SA, Thompson RH, Psutka S, Cheville JC, Thapa P, Tollefson M, Frank I, World Journal of Urology, 1/6/2017
• Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes  
  Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH, BJU Int, 1/1/2017
• Complications and outcomes associated with surgical management of renal cell carcinoma involving the liver: a matched cohort study  
  Joyce DD, Psutka SP, Thompson RH, Boorjian SA, Cheville JC, Stewart-Merrill SB, Lohse C, Costello BA, Que F, Leibovich BC, Urology, 1/1/2017
• Postoperative Surveillance for Renal Cell Carcinoma  
  Merrill SB, Urologic Clinics of North America, 1/1/2017
• Resource use in the last year of life among patients who died with versus of prostate cancer  
  Dinan MA, Li Y, Zhang Y, Stewart SB, Curtis LH, George DJ, Reed SD, Clinical Genitourinary Cancer, 1/1/2016
• Decreased skeletal muscle mass is associated with an incrased risk of mortality following radical nephrectomy for localized renal cell cancer  
  Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK, Journal of Urology, 1/1/2016
• Standardizing the definition for biochemical recurrence following radical prostatectomy: What PSA cut-point best reflects a durable rise and predicts systemic progres...  
  Toussi A, Stewart-Merrill SB, Boorjian SA, Psutka SP, Thompson RH, Frank I, Tollefson MK, Gettman MT, Bergstralh E, Carlson RE, Karnes RJ, Journal of Urology, 1/1/2016
• Oncologic Surveillance in Bladder Cancer Following Radical Cystectomy: A Systematic Review and Meta-Analysis  
  Stewart-Merrill SB, Alahdab F, Benkhadra K, Wang Z, Sorita A, Boorjian SA, Frank I, Murad MH, Urologic Oncology, 1/1/2016
• Concordance of pathologic features between metastatic sites and the primary tumor in surgically resected metastatic renal cell carcinoma  
  Psutka SP, Cheville JC, Costello BA, Stewart-Merrill SB, Lohse CM, Leibovich BC, Boorjian SA, Thompson RH, Urology, 1/1/2016
• Evaluation of Current Surveillance Guidelines Following Radical Cystectomy and Proposal of a Novel Risk-based Approach  
  Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka S, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson M, Frank I, Urologic Oncology, 1/1/2015
• Oncologic Surveillance Following Surgical Resection for Renal Cell Carcinoma: A Novel Risk-based Approach  
  Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka S, Lohse CM, Cheville JC, Leibovich BC, Frank I, Journal of Clinical Oncology, 1/1/2015
• The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma  
  Psutka SP, Boorjian SA, Lohse CM, Stewart SB, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH, Urologic Oncology, 1/1/2015
• Mortality after radical cystectomy: The impact of obesity versus adiposity after adjusting for skeletal muscle wasting  
  Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Frank I, Carrasco A, Stewart SB, Tarrell R, Thapa P, Tollefson MK, Journal of Urology, 1/1/2015
• Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective  
  Stewart SB, Boorjian SA, Urologic Oncology, 1/1/2015
• Clinical and radiographic predictors of the need for inferior vena caval resection during nephrectomy for patients with renal cell carcinoma and caval tumor thrombus  
  Psutka SP, Boorjian SA, Thompson RH, Schmit GD, Schmitz JJ, Bower TC, Stewart SB, Lohse CM, Cheville JC, Leibovich BC, British Journal of Urology International, 1/28/2014
• Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses  
  Thompson RH, Atwell T, Schmit G, Lohse C, Kurup AN, Weisbrod A, Psutka SP, Stewart SB, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, European Urology, 1/6/2014
• Does the multidisciplinary approach improve oncologic outcomes in men undergoing surgical treatment for prostate cancer?  
  Stewart SB, Robertson CN, Freedland SJ, Polascik TJ, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW, Banez LL, International Journal of Urology, 1/1/2014
• Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines  
  Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse C, Boorjian SA, Leibovich BC, Journal of Clinical Oncology, 1/1/2014
• Diabetes mellitus is independently associated with an increased risk of mortality among clear cell renal cell carcinoma patients  
  Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH, Journal of Urology, 1/1/2014
• Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy  
  Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SJ, Bergstralh E, Rangel L, Karnes RJ, Prostate Cancer and Prostatic Dis, 1/1/2014
• A framework to evaluate the cost-effectiveness of the NADiA ProsVue PSA slope to guide adjuvant radiotherapy among men with high-risk characteristics following prostat...  
  Reed AD, Stewart SB, Scales CD, Moul JW, Value Health, 1/1/2014
• Sarcopenia is patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality  
  Psutka SP, Carrasco A, Moynagh M, Schmit G, Stewart SB, Boorjian SA, Frank I, Thapa P, Tarrell R, Tollefson MK, Cancer, 1/1/2014
• Will the future of health care lead to the end of the robotic golden years?  
  Biehn Stewart S, Reed SD, Moul JW, European Urology, 1/22/2012
• Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?  
  Stewart SB, Scales Jr. C, Moul JW, Reed SD, Prostate Cancer Prostatic Dis, 1/1/2012
• Join now to see all

Books/Book Chapters

• Clinical Review of Surgery: Absite Review. 
  Chapter: Urology. 
  Stewart SBEditors: Sapan S. Desai and Danny O. Jacobs.Catalyst, Durham, NCEdition 3rd,2009

Abstracts/Posters

• Patterns of Surveillance Intensity in Kidney Cancer.
  Merrill SB, Schaefer E, Hollenbeak C, American Urologic Association Annual Meeting, Boston, MA, 1/12/2017
• Oncologic Surveillance Following Surgical Resection for Renal Cell Carcinoma: A Novel Risk-based Approach.
  Stewart SB, Thompson RH, Boorjian SA, Psutka S, Lohse CM, Cheville JC, Leibovich BC, Frank I, American Urologic Association Annual Meeting; Society of Urologic Oncology Annual Meeting, Bethesda, MD, 2014; New Orleans, LA, 2015, 1/15/2015
• Diabetes Mellitus is Associated with an Increased Risk of Cancer-Specific Mortality among Patients with Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
  Psutka SP, Stewart SB, Lohse C, Tollefson MK, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH, Genitourinary Cancers Symposium: American Society of Clinical Oncology (GU ASCO) Annual Meeting, San Francisco, CA, 1/30/2014
• AUA and NCCN surveillance guidelines for RCC: do they effectively capture recurrences following nephrectomy?
  Stewart SB, Thompson, RH, Psutka S, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Genitourinary Cancers Symposium: American Society of Clinical Oncology (GU ASCO) Annual Meeting, San Francisco, CA, 1/30/2014
• Standardizing the definition for biochemical recurrence following radical prostatectomy: what PSA cut-point best reflects a durable rise and predicts systemic progress...
  Stewart SB, Boorjian SA, Psutka S, Cheville JC, Thapa P, Tarrell R, Tollefson M, Thompson RH, Frank I, American Urologic Association Annual Meeting, Orlando, FL, 1/15/2014
• When can oncologic surveillance following radical cystectomy be safely discontinued?
  Stewart SB, Boorjian SA, Psutka S, Cheville JC, Thapa P, Tarrell R, Tollefson M, Thompson RH, Frank I, American Urologic Association Annual Meeting, Orlando, FL, 1/15/2014
• EAU and NCCN surveillance guidelines for bladder cancer: do they effectively capture recurrences following cystectomy?
  Stewart SB, Boorjian SA, Psutka S, Cheville JC, Thapa P, Tarrell R, Tollefson M, Thompson RH, Frank I, American Urologic Association Annual Meeting; Genitourinary Cancers Symposium: American Society of Clinical Oncology (GU ASCO) Annual Meeting, San Francisco, CA, 2014; Orlando, FL, 2014, 1/15/2014
• Resource use and costs in the last year of life among medicare beneficiaries who died from prostate cancer versus with prostate cancer between 2000 and 2007.
  Dinan MA, Li Y, Zhang Y, Curtis LH, George DJ, Stewart SB, Reed SD, American Society of Clinical Oncology, Chicago, IL, 1/31/2013
• Diabetes Mellitus is Associated with an Increased Risk of Cancer-Specific Mortality among Patients with Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
  Psutka SP, Stewart SB, Lohse C, Tollefson MK, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/4/2013
• The TNM lymph node classification for renal cell carcinoma: Does less specific nodal parameters allow similar prognostication?
  Stewart SB, Thompson, RH, Psutka S, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/4/2013
• Preoperative risk factors for extensive positive surgical margins following radical prostatectomy.
  Stewart SB, Banez LL, Madden JF, Gerber L, Moul JW, Southeastern Section of the American Urologic Association Annual Meeting, Amelia Island, FL, 1/22/2012
• Cost-effectiveness of chemoprevention with finasteride for prostate cancer varies across subgroups defined by family history and genetic polymorphisms.
  Reed SD, Scales Jr. C, Stewart SB, Sun J, Moul J, Schulman K, Xu J, American Urologic Association Annual Meeting, San Francisco, CA, 1/29/2010
• Risk stratification for prostate cancer using age-specific PSA quartiles.
  Uhlman M, Sun L, Stackhouse D, Stewart SB, Robertson C, Polascik, Albala D, Moul J, American Urologic Association Annual Meeting, San Francisco, CA, 1/29/2010
• The influence of obesity on perioperative parameters in robotic versus open prostatectomy cases at a single center that specializes in both techniques.
  Stewart SB, Tsivian M, Banez L, Gan T, Robertson C, Walther P, Polascik T, Mouraview V, Albala D, Moul J, Southeastern Section of the American Urologic Association Annual Meeting, Miami, FL, 1/11/2010
• Does the multidisciplinary approach improve oncologic outcomes in men undergoing surgical treatment for prostate cancer?
  Stewart SB, Banez LL, Xie D, Freedland SJ, Robertson CN, Polascik TJ, Walther PJ, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/8/2010
• Utilization trends of a multidisciplinary prostate cancer clinic: initial 5-year experience from The Duke Prostate Center.
  Stewart SB, Banez LL, Xie D, Freedland SJ, Robertson CN, Polascik TJ, Walther PJ, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/8/2010
• Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
  Stewart SB, Scales Jr. C, Moul JW, Reed SD, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/8/2010
• Does the extent of positive surgical margins influence biochemical recurrence following radical prostatectomy?—Results from the Duke Prostate Center.
  Stewart SB, Madden JF, Gerber L, Moul JW, Banez LL, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/1/2010
• The influence of obesity on perioperative parameters in robotic versus open prostatectomy cases at a single center that specializes in both techniques.
  Stewart SB, Tsivian M, Banez L, Gan T, Robertson C, Walther P, Polascik T, Mouraview V, Albala D, Moul J, Society of Urologic Oncology with World Urological Oncology Federation Annual Meeting, Bethesda, MD, 1/2/2009
• Outcomes of radical prostatectomy in elderly men in the United States.
  Stewart SB, Scales CD, Curtis LH, Schulman KA, Moul JW, Southeastern Section of the American Urologic Association Annual Meeting, San Diego, CA, 1/6/2008
• A phase I study of the novel proteasome inhibitor, PR-171, in patients with hematological malignancies.
  Biehn SE, Voorhees PM, Garcia RA, O’Conner OA, Orlowski RZ, Doris Duke Charitable Foundation Clinical Research Annual Meeting, Duke Farms, Hillsborough, NJ, 1/21/2006
• Extended follow-up of outcome measures and analysis of prognostic factors in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposom...
  Biehn SE, Moore DT, Voorhees PM, Garcia RA, Lehman MJ, Dees EC, Orlowski RZ, American Society of Clinical Oncology Annual Meeting, Atlanta, GA, 1/2/2006
• Extended follow-up of outcome measures and analysis of prognostic factors in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposom...
  Biehn SE, Moore DT, Voorhees PM, Garcia RA, Lehman MJ, Dees EC, Orlowski RZ, ASCO, 1/1/2006
• Induction of organelle biogenesis by Ca2+-ATPase (SERCA1a) expression.
  Biehn SE, Czymmek KJ, Karin NJ, American Society for Cell Biology 42nd Annual International Meeting, Groton, CT, 2002; New Orleans, LA, 2002; San Francisco, CA, 2002, 1/14/2002
• Join now to see all

Lectures

• Complications of Urinary Diversions. 
  Boston, MA - 1/16/2017
• Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival. 
  Boston, MA - 1/12/2017
• Prostate Cancer Screening: The continuing controversy with PSA. 
  Penn State Health St. Joseph Medical Center, Reading, PA - 1/19/2016
• Safety of Active Surveillance in Specific Prostate Cancer Subgroups. 
  Hot Springs, VA - 1/9/2016
• Optimization of RCC Surveillance following Surgery. 
  San Diego, CA - 1/7/2016
• Oncologic Surveillance Following Radical Cystectomy: An Individualized Risk-based Approach. 
  Washington, DC, 2015; San Diego, CA, 2016 - 1/5/2016
• Surveillance strategies in bladder cancer following radical cystectomy: a systematic review and meta-analysis. 
  Chicago, IL, 2014, New Orleans, LA, 2015 - 1/15/2015
• AUA and NCCN surveillance guidelines for RCC: do they effectively capture recurrences following nephrectomy? 
  Orlando, FL - 1/15/2014
• Time trends in perioperative and long-term mortality following cystectomy. 
  Chicago, IL - 1/10/2014
• Does the extent of positive surgical margins influence biochemical recurrence following radical prostatectomy?—Results from the Duke Prostate Center. 
  Amelia Island, FL - 1/22/2012
• Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective? 
  Washington, DC - 1/14/2011
• A True Multi-Disciplinary Clinic for men with newly Diagnosed Prostate Cancer 2004-2009. 
  Orlando, FL - 1/9/2011
• Multidisciplinary Prostate Cancer Approach: The Duke Experience. 
  San Francisco, CA - 1/29/2010
• Are there gains in cost-effectiveness of chemoprevention for prostate cancer when targeting men at higher risk based on family history and genetic markers. 
  Toronto, Canada - 1/24/2010
• Nephrolithiasis and ureteral obstruction: Etiology, Diagnosis and Management. 
  Atlantic Beach, NC - 1/17/2010
• The prevalence of depression in Myasthenia Gravis. 
  Chapel Hill, NC - 1/20/2005
• Join now to see all

Other

• Governor Wolf’s diagnosis brings attention to prostate cancer. 
  Merrill S, National Public Radio—Smart Talk: WITF radio
  1/29/2016
• Induction of organelle biogenesis by Ca2+-ATPase (SERCA1a) expression. 
  Biehn SE, Czymmek KJ, Karin NJ, Senior Thesis
  University of Delaware - 1/1/2002